在β-腺受体亚型中偏差激进主义:药物开发前景
Martin C Michel1, Ongun Onaran2
1Department of Pharmacology, University Medical Center, Johannes Gutenberg University, Mainz, Germany. marmiche@uni-mainz.de.
Handbook of experimental pharmacology
|September 13, 2025
概括
实现药物选择性对于最小化副作用至关重要. 偏差激进主义为功能性标选择性提供了潜力,但其在药物开发中的应用仍然是复杂和具有挑战性的.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
- 分子生物学分子生物学
背景情况:
- 药物选择性旨在最大限度地提高所需的治疗效果,同时最大限度地减少不良副作用.
- 传统的选择性策略包括目标特异性,药理动力学和差异性组织疗效.
- 偏差激动性,其中一个连接体优先激活一个信号通路而不是其他信号通路,呈现出一种更细微的方法.
研究的目的:
- 探索药物开发中偏见激进主义的概念和挑战.
- 了解偏见激进主义在实现功能性目标选择性方面的作用.
- 评估识别和利用偏向的连接体配置文件以获得治疗效益的复杂性.
主要方法:
- 对现有关于偏见性激励和药物选择性的文献的审查.
- 分析评估连接物偏差的复杂性,特别是对于β-腺受体.
- 讨论在药物研究早期确定所需偏见配置文件的挑战.
主要成果:
- 偏见激进主义是一种复杂的现象,很难准确评估.
- 贝塔上腺受体作为研究偏向激进主义的关键模型,但研究结果往往是不确定的.
- 目前评估偏差信号的方法对药物开发构成重大挑战.
结论:
- 偏差激进主义在药物设计中增强功能标选择性方面具有前景.
- 评估中的重大复杂性阻碍了在药物发现中使用偏见激进主义的前景.
- 需要进一步的研究来克服这些挑战,并有效地利用偏见激进主义.
相关概念视频
01:25Drug-Receptor Interaction: Agonist
3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K
01:17Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
1.4K
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
1.4K
01:31Adrenergic Receptors: ɑ Subtype
2.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.6K
01:25Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers
1.2K
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
1.2K
01:26Adrenergic Receptors: β Subtype
3.4K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.4K
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.1K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K